Innovative CAR T cell therapy targets two proteins to combat aggressive brain tumor growth

FHS
March 15, 2024
10:59 am

Breakthrough in Brain Cancer Treatment: Dual-Target CAR T Cell Therapy Shows Promise in Early Clinical Trial.

Eli Lilly, Boehringer gain FDA approval for type 2 diabetes tablets

The FDA has approved Jardiance 10mg and 25mg tablets to treat type 2 diabetes in children aged 10 years and above. Credit: i viewfinder /

June 22, 2023

Marinomed Biotech AG reports preliminary financial figures for the first half of 2024 – Biotech Investments

EQS-News: Marinomed Biotech AG / Key word(s): Preliminary Results/Half Year Results Marinomed Biotech AG reports preliminary financial figures for the first half of 2024 20.08.2024

August 21, 2024

Bluebird snags more outcomes-based coverage for its $3M+ sickle cell gene therapy

A second outcomes-based agreement with an unidentified payer is now in the books for bluebird bio’s new $3.1 million sickle cell gene therapy, the company

January 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.